Novonix Limited carries a market capitalization of 219.87M, placing it among publicly traded companies globally. Its enterprise value stands at 46.98M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 219.87M |
| Enterprise Value | 46.98M |
Novonix Limited currently has 636.20M shares outstanding.
| Shares Outstanding | 636.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Novonix Limited maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.93 |
| Quick Ratio | 0.77 |
| Debt / Equity | 49.92 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Novonix Limited's stock has declined approximately -36.25% over the past 52 weeks. The 50-day moving average sits at 0.26, while the 200-day moving average is 0.41.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.25% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.41 |
| Average Volume (20 Days) | N/A |
Novonix Limited holds 24.82M in cash and equivalents against 71.80M in total debt, resulting in a net debt position of 39.16M. Total book value stands at 112.74M, with working capital of -3.84M providing operational flexibility.
| Cash & Cash Equivalents | 24.82M |
| Total Debt | 71.80M |
| Net Debt | 39.16M |
| Equity (Book Value) | 112.74M |
| Book Value Per Share | N/A |
| Working Capital | -3.84M |
| Operating Cash Flow | N/A |
| Capital Expenditures | -54.48M |
| Free Cash Flow | -54.48M |
| FCF Per Share | N/A |
Novonix Limited's most recent stock split took place on May 29, 2020 with a 1000:1389 split ratio.
| Last Split Date | 5/29/2020 |
| Split Ratio | 1000:1389 |
Novonix Limited posts an Altman Z-Score of -1.75, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.75 |